Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis
Science · 2026
DOI: 10.1126/science.aeb0054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2026. Verfasst von Jingan Chen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Codon, Nonsense, Cystic Fibrosis, Nanoparticles, RNA, Transfer. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Gefördert von: National Institutes of Health, Cystic Fibrosis Foundation, J.P. Bickell Foundation.
Abstract (Originalsprache)
Suppressor transfer RNAs (sup-tRNAs) can rescue disease-causing nonsense mutations by promoting readthrough of premature termination codons (PTCs). Their clinical translation is limited by suboptimal activity and inefficient in vivo delivery. In this work, we combined site-specific chemical modification of sup-tRNAs with cargo-tailored pulmonary lipid nanoparticle (LNP) engineering to overcome these barriers. Incorporation of N 1 -methyladenosine in sup-tRNAs improved PTC readthrough, enhanced tRNA aminoacylation, prolonged functional persistence, and reduced innate immune activation. High-throughput ionizable lipid screening and formulation optimization identified a sup-tRNA–tailored LNP that efficiently delivered chemically modified sup-tRNAs to the lung. This approach restored cystic fibrosis transmembrane conductance regulator (CFTR) expression and function in bronchial epithelial cells, mouse models, and patient-derived organoids. Thus, LNP-delivered, chemically engineered sup-tRNAs represent a potential therapeutic platform for treating nonsense mutations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON, Canada.
- Institute of Biomedical Engineering, University of Toronto, Toronto, ON, Canada.
- Department of Chemistry, University of Toronto, Toronto, ON, Canada.
- Program in Translational Medicine, The Hospital for Sick Children Research Institute, Toronto, ON, Canada.
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.
- Pediatric Gastroenterology, Department of Pediatrics, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Jingan Chen, Muye Zhou, Songtao Dong, Fanglin Gong, Breanna Y Seto, Zhichang Peter Zhou, Yue Xu, Sijin Luozhong, Colette Maya Macarios, Santiago Tijaro-Bulla, Tanja Gonska, Jim Hu, Haissi Cui, Bowen Li
Förderung
- National Institutes of Health
- Cystic Fibrosis Foundation
- J.P. Bickell Foundation
- Harrington Discovery Institute, University Hospitals
- Leslie Dan Faculty of Pharmacy, University of Toronto
- Connaught Fund
- Canada Research Chairs
- Canadian Institutes of Health Research
Zitieren
APA
Chen, J., Zhou, M., Dong, S., Gong, F., Tennakoon, R., Seto, B. Y., Chen, Z. R., Zhou, Z. P., Pan, J., Xu, Y., Luozhong, S., Macarios, C. M., Tijaro-Bulla, S., Gonska, T., Hu, J., Cui, H., & Li, B. (2026). Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis. Science. https://doi.org/10.1126/science.aeb0054
Vancouver
Chen J, Zhou M, Dong S, Gong F, Tennakoon R, Seto BY, et al. Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis. Science. 2026. doi:10.1126/science.aeb0054
BibTeX
@article{Chen2026,
author = {Chen, Jingan and Zhou, Muye and Dong, Songtao and Gong, Fanglin and Tennakoon, Rasangi and Seto, Breanna Y and Chen, Ziyan Rachel and Zhou, Zhichang Peter and Pan, Jingyi and Xu, Yue and Luozhong, Sijin and Macarios, Colette Maya and Tijaro-Bulla, Santiago and Gonska, Tanja and Hu, Jim and Cui, Haissi and Li, Bowen},
title = {Nonviral delivery of chemically modified tRNA rescues nonsense mutations in cystic fibrosis},
journal = {Science},
year = {2026},
doi = {10.1126/science.aeb0054}
}
EUVIMED